3,4-Methylenedioxy-N-hydroxyamphetamine
Psychedelic and entactogen
From Wikipedia, the free encyclopedia
3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH), also known as N-hydroxy-MDA, is an entactogen, psychedelic, and stimulant of the phenethylamine, amphetamine, and MDxx families.[2] It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of FLEA (MDMOH).[1]
- None
| |
 | |
| Clinical data | |
|---|---|
| Other names | MDOH; MDH; N-Hydroxy-MDA |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen; Entactogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 3–6 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H13NO3 |
| Molar mass | 195.218 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin listed the dose range as 100 to 160 mg orally and its duration as approximately 3 to 6 hours.[1] He describes MDOH as being very psychedelic and producing increased pleasure in beauty and nature.[1] Shulgin also mentioned several negative side effects also seen with MDMA ("Ecstasy") such as difficulty urinating and internal dryness.[1] He has noted that the properties and effects of MDOH are very similar or near-identical to those of MDA and that MDOH might be converted into MDA in the body.[1]
Interactions
Chemistry
Society and culture
Legal status
Canada
MDOH is a controlled substance in Canada.[3]
United States
MDOH is a schedule I controlled substance in the United States.[4]